Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
23.19
+0.01 (0.04%)
At close: Oct 16, 2026, 4:00 PM EDT
23.18
-0.01 (-0.04%)
After-hours: Oct 16, 2026, 7:32 PM EDT
Collegium Pharmaceutical Revenue
Collegium Pharmaceutical had revenue of $199.88M in the quarter ending June 30, 2026, with 6.32% growth. This brings the company's revenue in the last twelve months to $808.21M, up 14.31% year-over-year. In the year 2025, Collegium Pharmaceutical had annual revenue of $780.57M with 23.62% growth. That makes Collegium Pharmaceutical the 8,625th largest company in the world by revenue and 1,934th in the United States.
Revenue (ttm)
$808.21M
Revenue Growth
+14.31%
P/S Ratio
0.93
Revenue / Employee
$1,910,657
Employees
423
Market Cap
754.96M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 780.57M | 149.12M | 23.62% |
| Dec 31, 2024 | 631.45M | 64.68M | 11.41% |
| Dec 31, 2023 | 566.77M | 102.83M | 22.17% |
| Dec 31, 2022 | 463.93M | 187.07M | 67.56% |
| Dec 31, 2021 | 276.87M | -33.15M | -10.69% |
| Dec 31, 2020 | 310.02M | 13.32M | 4.49% |
| Dec 31, 2019 | 296.70M | 16.29M | 5.81% |
| Dec 31, 2018 | 280.41M | 251.94M | 884.73% |
| Dec 31, 2017 | 28.48M | 26.77M | 1,564.29% |
| Dec 31, 2016 | 1.71M | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Tilray Brands | 963.10M |
| Evotec SE | 819.47M |
| Pacira BioSciences | 746.16M |
| Amphastar Pharmaceuticals | 730.02M |
| Ironwood Pharmaceuticals | 389.32M |
| Evolus | 316.49M |
| Harrow | 275.59M |
| Kamada | 191.85M |
COLL News
- 12 days ago - Collegium Launches "Start Talking ADHD" with Practical Support to Help Families Navigate Care, School and Everyday Life - GlobeNewsWire
- 25 days ago - Collegium Pharmaceutical initiated with an Outperform at Oppenheimer - TheFly
- 4 weeks ago - Collegium Pharmaceutical Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 4 weeks ago - Collegium Pharmaceutical Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 5 weeks ago - Leerink bullish on Collegium Pharmaceutical, initiates with an Outperform - TheFly
- 5 weeks ago - Collegium Pharmaceutical initiated with an Outperform at Leerink - TheFly
- 5 weeks ago - Collegium Pharmaceutical assumed with a Buy at Truist - TheFly
- 5 weeks ago - Collegium to Participate in Upcoming Investor Conferences - GlobeNewsWire